Samsung Biologics, Eli Lilly to establish biotech incubator in Incheon

Samsung Biologics, the biotech arm of Samsung Group, said Tuesday it has signed an agreement with US pharmaceutical giant Eli Lilly and Co. to set up a biotech incubator in the western city of Incheon.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.